Where Zimmer Biomet Holdings Stands With Analysts
Portfolio Pulse from Benzinga Insights
Zimmer Biomet Holdings (NYSE:ZBH) has received various analyst ratings in the last quarter, with 4 bullish, 6 somewhat bullish, 8 indifferent, and 1 somewhat bearish. The average 12-month price target for ZBH, according to 19 analysts, is $153.53, which has increased by 9.39% over the past month.
June 28, 2023 | 4:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Zimmer Biomet Holdings has received mixed analyst ratings, with a majority being bullish or indifferent. The average 12-month price target has increased, indicating a positive outlook.
The mixed analyst ratings, with a majority being bullish or indifferent, indicate a generally positive sentiment towards ZBH. The increase in the average 12-month price target suggests that analysts expect the stock price to rise, which could positively impact the stock in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100